Skip to main content
Top
Published in: Medical Oncology 1/2011

01-12-2011 | Original paper

Bladder metastasis of malignant melanoma: a case report and review of literature

Authors: Ozan Efesoy, Selahittin Cayan

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

Metastatic malignant melanoma of the bladder is extremely rare in clinical practice with less than 10 cases reported in the last 30 years in the English literature. We report a case of malignant melanoma metastasis into the bladder, and review of the pertinent literature. A 60-year-old woman with a history of malignant melanoma in the distal phalanx on the right middle finger, excised 8 years ago presented with gross hematuria and weight loss. She underwent cystoscopy and complete transurethral resection of the bladder tumor. Pathological examination showed metastatic malignant melanoma of the bladder mucosa. The patient eventually died 7 months after transurethral resection.
Literature
2.
go back to reference Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s urology. 8th ed. Philadelphia: Saunders; 2002. p. 2732–84. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell’s urology. 8th ed. Philadelphia: Saunders; 2002. p. 2732–84.
3.
go back to reference Lee CS, et al. Management of metastatic malignant melanoma of the bladder. Urology. 2003;62:35xi–35xiii. Lee CS, et al. Management of metastatic malignant melanoma of the bladder. Urology. 2003;62:35xi–35xiii.
4.
go back to reference Menendez Lopez V, Alvarez-Vijande Garcia R, Sole Arques M, Carretero Gonzalez P. Bladder metastasis of malignant melanoma: report of a case. Arch Esp Urol. 2002;55:1277–9.PubMed Menendez Lopez V, Alvarez-Vijande Garcia R, Sole Arques M, Carretero Gonzalez P. Bladder metastasis of malignant melanoma: report of a case. Arch Esp Urol. 2002;55:1277–9.PubMed
5.
go back to reference Demirkesen O, Yaycioglu O, Uygun N, Demir G, Yalcin V. A case of metastatic malignant melanoma presenting with hematuria. Urol Int. 2000;64:118–20.PubMedCrossRef Demirkesen O, Yaycioglu O, Uygun N, Demir G, Yalcin V. A case of metastatic malignant melanoma presenting with hematuria. Urol Int. 2000;64:118–20.PubMedCrossRef
6.
go back to reference Arapantoni-Dadioti P, Panayiotides J, Kalkandi P, Christodoulou C, Delides GS. Metastasis of malignant melanoma to a transitional cell carcinoma of the bladder. Eur J Surg Oncol. 1995;21:92–3.PubMedCrossRef Arapantoni-Dadioti P, Panayiotides J, Kalkandi P, Christodoulou C, Delides GS. Metastasis of malignant melanoma to a transitional cell carcinoma of the bladder. Eur J Surg Oncol. 1995;21:92–3.PubMedCrossRef
7.
go back to reference Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull. 1995;51:609–30.PubMed Lee SM, Betticher DC, Thatcher N. Melanoma: chemotherapy. Br Med Bull. 1995;51:609–30.PubMed
8.
go back to reference Huncharek M, Caubet JF, McGarry R. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 2001;1:75–81.CrossRef Huncharek M, Caubet JF, McGarry R. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 2001;1:75–81.CrossRef
9.
go back to reference Acquavella N, et al. Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J Immunother. 2008;31:569–76.PubMedCrossRef Acquavella N, et al. Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J Immunother. 2008;31:569–76.PubMedCrossRef
10.
go back to reference Barth A, Wanek LA, Morton DL. Prognostic factors in 1, 521 melanoma patients with distant metastases. J Am Coll Surg. 1995;18:193–201. Barth A, Wanek LA, Morton DL. Prognostic factors in 1, 521 melanoma patients with distant metastases. J Am Coll Surg. 1995;18:193–201.
Metadata
Title
Bladder metastasis of malignant melanoma: a case report and review of literature
Authors
Ozan Efesoy
Selahittin Cayan
Publication date
01-12-2011
Publisher
Springer US
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9730-x

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.